| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Wijngaard Peter is a Director at HEPA. Recent filings cover 8 purchases and 0 sales. Those positions are worth an estimated $29K at current prices.
Wijngaard Peter's largest disclosed position is in HEPA as Director, worth about $29K. Net of sales, the recent Form 4 record there shows accumulation of 38,000 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Nov 27, 2023 | HEPA Hepion Pharmaceuticals, Inc. | Director | Buy | 5,000 | $3.07 | $15,350.00 | +111.1% | |
| Sep 19, 2023 | HEPA Hepion Pharmaceuticals, Inc. | Director | Buy | 3,000 | $5.61 | $16,841.12 | +199.9% | |
| Feb 16, 2021 | HEPA Hepion Pharmaceuticals, Inc. | Director | Buy | 10,000 | $2.20 | $22,000.00 | +50.0% | |
| Dec 18, 2020 | HEPA Hepion Pharmaceuticals, Inc. | Director | Buy | 20,000 | $1.91 | $38,200.00 | New |